Zinc is a critical trace element for life; however, its involvement in various neurodegenerative diseases is well document \[[@CR1]\]. Within a subset of glutamatergic neurons, facilitated zinc transport into synaptic vesicles is entirely achieved through ZnT3 (encoded by the *Slc30a3* gene) \[[@CR2]\]. Interestingly, aberrant ZnT3 expression levels in the brain appear to be a common feature in Alzheimer's disease, Lewy-body dementia, and amyotrophic lateral sclerosis, in which abnormal cerebral zinc levels have been implicated in disease process \[[@CR3]--[@CR5]\]. Recent evidence from our laboratory suggests that zinc dyshomeostasis plays a role in the pathogenesis of Mucolipidosis IV (MLIV) \[[@CR6], [@CR7]\], which has since been corroborated by another group \[[@CR8]\]. MLIV is caused by the loss of TRPML1 function, which is a lysosomal cation channel encoded by the *MCOLN1* gene. The existing *Mcoln1*^*−/−*^ KO mice have been shown to mimic MLIV disease phenotype \[[@CR9]\], and is thus an excellent model to dissect pathological processes connected with zinc dyshomeostasis.

A detailed description of experimental methods, including the RNA-seq approach (Additional file [1](#MOESM1){ref-type="media"}: Table S1) and real-time qPCR primers (Additional file [1](#MOESM1){ref-type="media"}: Table S2) can be found in Additional file [1](#MOESM1){ref-type="media"}. Baseline transcript expression levels from *Mcoln1*^*−/−*^ KO and *Mcoln1*^*+/+*^ WT littermate control mice (aged 2--3 months) were adjusted for gene length and library size using the Transcripts Per Million (TPM) normalization. We generated a list of DGE using Galaxy's DeSeq2 analysis to further corroborate the TPM data (Additional file [2](#MOESM2){ref-type="media"}: Table S3). Gene ontology (GO) analysis of the RNA-seq data revealed significant DGE under the "zinc ion transmembrane transporter activity" category. This led us to look into *Slc30a3* mRNAs levels. Despite the variations within and between KO and WT samples, marked decrease in *Slc30a3* transcripts among the *Mcoln1*^*−/−*^ KO brain samples was consistently observed (Fig. [1](#Fig1){ref-type="fig"}a). DeSeq2 analysis showed a two-fold down-regulation of *Slc30a3* expression in KO brain samples (Additional file [2](#MOESM2){ref-type="media"}: Table S3, log2\[FC\] = − 0.8 ± 0.3, *p-value* = 0.02). The list also befittingly showed the reduction of *Mcoln1* transcripts (log2\[FC\] = − 0.7 ± 0.3, *p-value* = 0.03) as a consequence of exons 3 and 4 exclusion caused by the transgene. Indeed, the sequencing coverage for *Mcoln1* gene is in agreement with the excised exons that produced the KO phenotype \[[@CR9]\] (Additional file [1](#MOESM1){ref-type="media"}: Figure S1). Validation with real-time qPCR confirmed the reduced *Slc30a3* transcripts (Fig. [1](#Fig1){ref-type="fig"}b). Integrated density value (IDV) analysis (Fig. [1](#Fig1){ref-type="fig"}c) of Western blot experiments (Fig. [1](#Fig1){ref-type="fig"}d) further confirmed the RNA-seq and qPCR data. Although a sex-specific negative regulation of ZnT3 and Ap3d1 (a subunit of the AP3 complex) expression levels have been reported in mice exposed to incremental doses of the estrogen analog estradiol \[[@CR10]\], our data did not show such an effect since the animals were fed a standard chow. Nevertheless, this report prompted us to analyze the *Ap3d1* transcripts despite not identifying *Ap3d1* on the DGE list. Using real-time qPCR, we found a reduction in *Ap3d1* mRNA levels (Additional file [1](#MOESM1){ref-type="media"}: Figure S2), which parallels the reduction of *Slc30a3* mRNA and protein levels observed in the current study (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Baseline *Slc30a3* mRNA and Slc30a3 (ZnT3) protein expression levels. **a** Transcriptomic analysis of brain tissues from *Mcoln1*^*−/−*^ KO mice (KO1-KO3, *n* = 3) and *Mcoln1*^*+/+*^ WT (WT1-WT3, n = 3) littermate control mice. **b** Real-time qPCR analysis of relative *Slc30a3* mRNA expression levels from brain tissues taken from *Mcoln1*^*−/−*^ KO and *Mcoln1*^*+/+*^ WT littermate control mice. The qPCR experiments were done in triplicate wells, normalized using *18S rRNA*, and analyzed using the Standard Curve method. The data are represented as mean ± SD (\**p* \< 0.05, Student's *t*-test, paired, *n* ≥ 3). **c** Integrated density value analysis of Slc30a3 (ZnT3) protein bands normalized with beta-Actin bands from two independent Western blot experiments. The relative Slc30a3 protein expression levels in *Mcoln1*^*−/−*^ KO-A and KO-B mouse brains are significantly reduced in comparison to *Mcoln1*^*+/+*^ WT-A mouse brain (\*\**p* \< 0.01, Student's *t*-test, paired, *n* ≥ 2). **d** Representative Western blot image of ZnT3 (*green*; monomer: \~ 42 kDa; dimer: \~ 84 kDa) and beta-Actin proteins (*red*; \~ 41 kDa). Each lane corresponds to: L, protein ladder; 1, *Mcoln1*^*+/+*^ WT-A control brain; 2, *Mcoln1*^*+/−*^ heterozygote control brain; 3, *Mcoln1*^*−/−*^ KO-A brain; and 4, *Mcoln1*^*−/−*^ KO-B brain. The blot was probed with anti-beta-Actin mouse monoclonal antibody and anti-ZnT3 rabbit polyclonal antibody, and imaged using LICOR Odyssey Sa infrared scanner at 700 nm and 800 nm channels, respectively

MLIV disease phenotypes such as abnormal gait, hind-limb paralysis, and mortality are typically observed between six and 9 months \[[@CR9]\]. The significant reduction of *Slc30a3*/ZnT3 expression in *Mcoln1*^*−/−*^ KO brain tissue suggests that it may be used as a biomarker. Our previous reports that zinc dyshomeostasis may be a key pathological event that initiates neuronal death and contributes to progressive neurodegeneration in MLIV have been gaining ground and are independently confirmed by others. Whether the distinct reduction of *Slc30a3*/ZnT3 expression in *Mcoln1*^*−/−*^ KO mice is a cause or consequence of the disease remains to be elucidated. However, the concomitant downregulation of *Ap3d1*, a key AP3 complex subunit involved in co-targeting ZnT3 protein and vesicular glutamate transporter 1 (Vglut1) to synaptic vesicles \[[@CR11]\], suggests that the former argument may not be the case. Noteworthy is that oxidative stress has been implicated in MLIV \[[@CR12]\] and other neurodegenerative disorders \[[@CR1]\], and that reactive oxygen \[[@CR13]\] and nitrogen \[[@CR14]\] species have been shown to uncontrollably release chelatable zinc. Therefore, it may be that the reductions in *Slc30a3*/ZnT3 expression could reflect a cytoprotective role to limit the neurotoxic release of glutamatergic zinc-rich vesicles. The recent observations of augmented glutamate exocytosis in *Mcoln1*^*−/−*^ KO neurons \[[@CR15]\] and enhanced loading of glutamate into zinc-rich vesicles by ZnT3 and Vglut1 proteins \[[@CR11]\] lend further credence to the possibility that decreased S*lc30a3*/ZnT3 expression in certain brain disorders may be a negative feedback regulation to prevent or minimize both glutamate and zinc-induced cytotoxicity. Future proteomic studies using *Mcoln1*^*−/−*^ brain tissues are warranted to yield better insight into the mechanistic processes that underlie zinc dyshomeostasis in MLIV and other neurodegenerative diseases.

Additional files
================

 {#Sec1}

Additional file 1:Materials and methods. **Table S1.** Basic demographics, sample IDs, and RNA-seq reads for each mouse sample. **Table S2.** Tabulated list of real-time qPCR primers used to validate specific RNA-seq data. **Figure S1**. RNA-seq coverage for exons within the major mouse *Mcoln1* isoform. **Figure S2**. Baseline *Ap3d1* transcript levels of individual brain tissues taken from *Mcoln1*^*--/--*^ knockout (KO1-KO3, *n* = 3) and *Mcoln1*^*+/+*^ wild-type (WT1-WT3, n = 3) littermate control mice. (DOCX 5087 kb) Additional file 2:**Table S3.** Tabulated list of differentially expressed genes between *Mcoln1*^*−/−*^ KO and *Mcoln1*^*+/+*^ WT control samples using DESeq2. (DOCX 150 kb)
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